Hydromorphone Hydrochloride Patent Expiration
Hydromorphone Hydrochloride was first introduced by Fresenius Kabi Usa Llc
Hydromorphone Hydrochloride Patents
Given below is the list of patents protecting Hydromorphone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Dilaudid | US9248229 | Packaging system for oxygen-sensitive drugs | Mar 12, 2034 | Fresenius Kabi Usa |
| Dilaudid-hp | US9248229 | Packaging system for oxygen-sensitive drugs | Mar 12, 2034 | Fresenius Kabi Usa |
| Dilaudid | US9731082 | Drug container | Apr 23, 2032 | Fresenius Kabi Usa |
| Dilaudid-hp | US9731082 | Drug container | Apr 23, 2032 | Fresenius Kabi Usa |
| Dilaudid | US6589960 | Hydromorphone and hydrocodone compositions and methods for their synthesis |
Nov 09, 2020
(Expired) | Fresenius Kabi Usa |
| Dilaudid | US6589960 | Hydromorphone and hydrocodone compositions and methods for their synthesis |
Nov 09, 2020
(Expired) | Rhodes Pharms |
| Dilaudid-hp | US6589960 | Hydromorphone and hydrocodone compositions and methods for their synthesis |
Nov 09, 2020
(Expired) | Fresenius Kabi Usa |
| Palladone | US6589960 | Hydromorphone and hydrocodone compositions and methods for their synthesis |
Nov 09, 2020
(Expired) | Purdue Pharma Lp |
| Palladone | US5958452 | Extruded orally administrable opioid formulations |
Nov 04, 2014
(Expired) | Purdue Pharma Lp |
| Palladone | US5965161 | Extruded multi-particulates |
Nov 04, 2014
(Expired) | Purdue Pharma Lp |
| Palladone | US6335033 | Melt-extrusion multiparticulates |
Nov 04, 2014
(Expired) | Purdue Pharma Lp |
| Palladone | US6706281 | Melt-extrusion multiparticulates |
Nov 04, 2014
(Expired) | Purdue Pharma Lp |
| Palladone | US6743442 | Melt-extruded orally administrable opioid formulations |
Nov 04, 2014
(Expired) | Purdue Pharma Lp |
| Exalgo | US5702725 | Hydromorphone therapy |
Jul 07, 2014
(Expired) | Specgx Llc |
| Exalgo | US5914131 | Hydromorphone therapy |
Jul 07, 2014
(Expired) | Specgx Llc |
Hydromorphone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List